Aethlon Medical Starts First Trial of Device Against HIV
Luke Timmerman9/29/08
San Diego-based Aethlon Medical (OTCBB: AETH) said today it has begun the first clinical trial of a medical device to treat HIV. The device, called Aethlon Hemopurifier, filters viruses and immune-suppressing proteins, in order to help the immune system fight HIV. The trial, of six patients, is being conducted in India.
Luke Timmerman is the National Biotech Editor of Xconomy, and the Editor of Xconomy Seattle. E-mail him at ltimmerman@xconomy.com or follow him on Twitter at twitter.com/ldtimmerman.




